Several studies have shown that the dysregulation of the PI3K/Akt pathway is involved in cancer pathogenesis and prognosis, and PIK3CA gene mutations have been reported in several types of human cancers, including colorectal, breast and hepatocellular carcinomas (10–14). Here, PIK3CA is linked to hepatocellular carcinoma.